Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6090)
All Articles published online
|
Publishing Process of This Article
|
Sep 26, 2020 (publication date) through Mar 13, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Lemaire CC, Portilho ALC, Pinheiro LV, Vivas RA, Britto M, Montenegro M, Rodrigues LFF, Arruda S, Lyra AC, Cavalcante LN. Sweet syndrome as a paraneoplastic manifestation of cholangiocarcinoma: A case report. World J Clin Cases 2020; 8(18): 4122-4127 [PMID: 33024770 DOI: 10.12998/wjcc.v8.i18.4122] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v8/i18/4122.htm |
| Number | Citing Articles |
| 1 |
Mihai-Lucian Ciobica, Bianca-Andreea Sandulescu, Liana-Maria Chicea, Mihaela Iordache, Maria-Laura Groseanu, Mara Carsote, Claudiu Nistor, Ana-Maria Radu. The Constellation of Risk Factors and Paraneoplastic Syndromes in Cholangiocarcinoma: Integrating the Endocrine Panel Amid Tumour-Related Biology (A Narrative Review). Biology 2024; 13(9): 662 doi: 10.3390/biology13090662
|
| 2 |
Tejas P. Joshi, Sarah K. Friske, David A. Hsiou, Madeleine Duvic. New Practical Aspects of Sweet Syndrome. American Journal of Clinical Dermatology 2022; 23(3): 301 doi: 10.1007/s40257-022-00673-4
|
| 3 |
Richard E. Kast, Alex Alfieri, Hazem I. Assi, Terry C. Burns, Ashraf M. Elyamany, Maria Gonzalez-Cao, Georg Karpel-Massler, Christine Marosi, Michael E. Salacz, Iacopo Sardi, Pieter Van Vlierberghe, Mohamed S. Zaghloul, Marc-Eric Halatsch. MDACT: A New Principle of Adjunctive Cancer Treatment Using Combinations of Multiple Repurposed Drugs, with an Example Regimen. Cancers 2022; 14(10): 2563 doi: 10.3390/cancers14102563
|